Deals
Pfizer Said to Weigh Sale of Pump Unit Acquired in Hospira Deal
- Drugmaker could fetch about $2 billion from transaction
- Sale process is at very early stage, plans could change
This article is for subscribers only.
Pfizer Inc. is weighing a sale of the pumps and devices business it acquired in last year’s purchase of Hospira Inc., people with knowledge of the matter said.
The U.S. drugmaker could fetch about $2 billion from a potential sale, the people said, asking not to be identified as the details are private. The process is at a very early stage and the details could change, the people said. Pfizer may also choose not to sell the Hospira unit at this time, they said.